Hope comes in a clinical trial: Brad’s remarkable story
When Brad’s medullary thyroid cancer returned after a surgical procedure, he enrolled in a clinical trial. Now, his cancer is nearly undetectable.
Read Article
-
-
Providence researchers head to Chicago for leading cancer conference
Researchers at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, are helping shape the future of cancer care at the 2026 ASCO Annual Meeting in Chicago.
Read Article
-
Adoptive cell therapy: Phase III study open for people with advanced melanoma
Inside the IMA203 phase III trial enrolling patients at Providence Cancer Institute.
Read Article
-
It started with one bandage, and a patient’s smile
How novelty bandages have become a beloved tradition at Providence Cancer Institute Newberg Clinic.
Read Article
-
New guidelines for treating head and neck cancer could be a game changer
New ASCO guidelines are designed to make the full body of evidence accessible to clinicians across specialties, including those who may not work routinely with a head and neck surgeon.
Read Article
-
Pioneering immunotherapy clinical trial enrolling patients with advanced cancers
A new medication called M3T01, developed at Providence Cancer Institute, takes a different approach to immunotherapy.
Read Article
-
VOICES of Black Women: A community study in cancer prevention and care
A new study focused on stories will change health outcomes for Black women.
Read Article
-
Leading the way: Providence researchers at AACR Annual Meeting
The annual AACR meeting draws the most innovative cancer researchers seeking breakthroughs in treatments.
Read Article
-
A quiet lifeline: Meet the volunteer at Jill Lematta Learning Center
Cancer resources and compassion are plentiful in a quiet space at Providence Cancer Institute Franz Clinic.
Read Article
-
Gene therapy shows promising results against multiple myeloma
This study is now enrolling patients at Providence Cancer Institute – the only site outside of Australia.
Read Article
-
Q&A: Colon cancer in younger adults, when to screen, symptoms and prevention
Dr. Kelly Perlewitz answers timely questions about the rise of colon cancer cases in younger adults.
Read Article
-
Celebrating oncology social workers: Compassion, expertise and impact
We celebrate the work of oncology social workers, whose work is essential, transformative and deeply human.
Read Article
-
6 things everyone should know about oncology palliative care
Palliative care can help manage pain, fatigue, anxiety and so much more – at any stage of cancer treatment.
Read Article
-
Clinical trial seeks better first-line therapy for follicular lymphoma
The study may redefine care for many people at the earliest stage of their treatment.
Read Article
-
Where curiosity meets impact: Women in science at Providence Cancer Institute
Get to know the women of the Immune Monitoring Laboratory and how their curiosity, tenacity and passion are driving progress in cancer research at Providence Cancer Institute.
Read Article
-
Why patients in rural areas need access to quality clinical trials
Dr. Natasha Edwin advocates for making more quality clinical trials available for patients in rural communities.
Read Article
-
A new strategy for treating locally advanced cervical cancer
A new study aims to move cervical cancer care forward and improve the chance of long-term remission for more patients.
Read Article
-
Personalizing lymphoma treatment: New study seeks better outcomes
A targeted therapy being evaluated in a clinical trial may improve survival for high-risk patients with diffuse large B-cell lymphoma.
Read Article
-
From patient to volunteer: Marge’s gift of gratitude
Marge received treatment for pancreatic cancer at Providence Cancer Institute and then volunteered in the infusion center to help the care team that supported her.
Read Article
-
Reflecting on 2025, building toward 2026
Catch the 2025 highlights from Providence Cancer Institute in this year-end recap focused on research advancements, caregiver recognition and community engagement.
Read Article
-
Loading More...
